Roche Diagnostics Corporation Confirm Anti-Er (Sp1) Primary Antibody

Roche Diagnostics Corporation confirm anti-er (sp1) primary antibody (; this antibody is intended for in vitro diagnostic (ivd) use. ventana medical systems, inc. (ventana) confirm anti-estrogen receptor (er) (sp1) rabbit monoclonal primary antibody is a rabbit monoclonal antibody (igg) that is intended for laboratory use for the qualitative detection of estrogen receptor (er) antigen in sections of formalin fixed, paraffin embedded tissue on a ventana automated slide stainer with ventana detection kits and ancillary reagents. this antibody has been optimally diluted for use with ventana iviewtm dab detection kit. light microscopy is used to detect the staining of cell components. confirm anti-er (sp1) is directed against an epitope present on human er alpha protein located in the nucleus of er positive normal and neoplastic cells. confirm anti- er (sp1) is indicated as an aid in the management, prognosis, and prediction of therapy outcome of breast cancer. the clinical interpretation of any staining, or the absence of staining, must be complemented by morphological studies and evaluation of proper controls. evaluation must be made by a qualified pathologist within the context of the patients clinical history and other diagnostic tests. prescription only. - ROCHMSD (Additional S&H or Hazmat Fees May Apply)